-
Comment Randomized Controlled Trial
In inpatients with COVID-19 who need supplemental oxygen, lenzilumab increased ventilation-free survival.
- Vincent J Mariano and Eleftherios Mylonakis.
- Rhode Island Hospital/Brown University, Providence, Rhode Island, USA (V.J.M., E.M.).
- Ann. Intern. Med. 2022 Apr 1; 175 (4): JC39JC39.
AbstractTemesgen Z, Burger CD, Baker J, et al. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022;10:237-46. 34863332.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..